Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis

References

• Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536–41.
   PubMed Web of Science ®Google Scholar
• Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003;4:1093–101.
   PubMed Web of Science ®Google Scholar
• Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol 2006;18:665–9.
   PubMed Web of Science ®Google Scholar
• Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116:1317–26.
   PubMed Web of Science ®Google Scholar
• Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007;81:1258–68.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6:1245–52.
   PubMed Web of Science ®Google Scholar
• Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008;127:78–88.
   PubMed Web of Science ®Google Scholar
• Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 2004;95:91–5.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Klippel JH, Stone JH, Crofford LJ, White PH. Primer on the rheumatic diseases. 13th edn. Atlanta, GA: Arthritis Foundation, 2008.
   Google Scholar
• Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002;169:5912–18.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486–91.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–73.
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345–52.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963–70.
   PubMed Web of Science ®Google Scholar
• Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000;164:2832–8.
   PubMed Web of Science ®Google Scholar
• Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 2007;56:3968–76.
   PubMed Web of Science ®Google Scholar
• Khademi M, Illes Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169–76.
   PubMed Web of Science ®Google Scholar
• Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006;203:1413–18.
   PubMed Web of Science ®Google Scholar
• Saita N, Goto E, Yamamoto T, Cho I, Tsumori K, Kohrogi H, Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 2002;128:42–50.
   PubMed Web of Science ®Google Scholar
• Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin MJ, Nishi N, Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 2002;99:809–16.
   PubMed Web of Science ®Google Scholar
• Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997;99:2452–61.
   PubMed Web of Science ®Google Scholar
• Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998;273:16976–84.
   PubMed Web of Science ®Google Scholar
• Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003;170:3631–6.
   PubMed Web of Science ®Google Scholar
• Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK. Tim-3–galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology 2009;214:342–9.
   PubMed Web of Science ®Google Scholar
• Ryder LR, Woetmann A, Madsen HO, Odum N, Ryder LP, Bliddal H, Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis. Scand J Rheumatol 2010; 39:279–86.
   Google Scholar